about_t.gif (3996 bytes)
¡@

·ö§bªº¨Ó¾ú¡BºØÃþ»P­ì¦]
Dementia History, Type, Causes Explained

by Ronni Chernoff, Ph.D.
Professor of Nutrition & Dietetics, University of Arkansas, U.S.A.
From: The Soy Connection, U.S.A., July 2003


·í¤H¤fÅܦѡA´¶¹M¦a·|²£¥Í»{ª¾·l®`(Cognitive Impairment)¡AºÙ¬°·ö§b(Dementia)¡A¥¦±N¦¨¬°°·±d·ÓÅU¨t²Î¡A¤é¯q¼W¦hªº­t¾á¡C·í·ö§bªºµo¥Í²v¦ü¥G·U¨Ó·U¦hªº®É­Ô¡A¦~¦Ñªº¦¨¤H«o´Á«Ý¨ä¯à°÷§ó©µªø¹Ø©R¡A¬O¨Æ¹ê¡C¦~¦Ñªº­Ó¤H±NªíÅS¨Ï¨ä§óªø¤[¦s¬¡ªº»{ª¾¾÷¯à³à¥¢¡A³oºØ¥i¯à©Ê±N¤j´T¼W¥[¡C

³\¦h°·±dªºÂ¾·~¤H¾D¹J¨ì¯S®íªº§íÆ{(Depression)¡Aĸ¦k(Delirium)¥H¤Î·ö§b¡A¥i¿×¤@­Ó¬D¾Ô¡C³q±`§íÆ{¦b¦~¦Ñªº¦¨¤H¤ñ¤j¦h°·±dªºÂ¾·~¤H¡A§ó´¶¹M·|µo¥Í¡C¥¦¥i¥HªvÀø¡A¦ý³Ì¥ý¥²¶·¥ý¸g¤©¶EÂ_¬°©y¡C§íÆ{ªº­Ó¤H¡A®É±`¸gÅç°O¾Ð·l®`¡A¦ý«oªíÅS¨ä§¹¾ã¥¼·l°O¾Ð¾÷¯à¤Î´N¨ä¦~ÄÖªº¾A©y»y¨¥§Þ¥©¡Cĸ¦k«Y®É±`¦³Ãö¯e¯f§Ö³tµo¥Íªº¤£¥¿±`ª¬ºA¡Aµu¼È«ùÄò¦Ó»P¤@¨Ç©w¦V¤O»Ùê(Disorientation)¤Î®e©öÅܤƪº¨ÆÂݦ^¾Ð¦³©ÒÃö³s¡C·ö§bÁÍ©óÀHµÛ©w¦V¤O»Ùꥢ»y¯g(Aphasia)¡A°O¾Ð³à¥¢(Memory Loss)¦Ó±N¤é¯q¼W¶i¡C

·í­Ó¤H³Q¶EÂ_¬°¿©±w·ö§b¥H«e¡A·|²£¥Í¤@ºØª¬ºA¡AºÙ¬°½w©Mªº»{ª¾·l®`(Mild Cognitive Impairment, MCI)¡A¥¦¥i¯à¬Æ¬°©úÅã¡C¿©±wMCIªº­Ó¤H¡A¥i¯à©ê«è¨ä°O¾Ð»Ùê°ÝÃD¡A¦ý¥L­Ì³q±`¶EÂ_´ú¸Õµ²ªG©|¥i¡A½Ñ¦p¡A¨C¤é¥Í¬¡¬¡°Êµû»ù(¯à°÷·ÓÅU¦Û¤vªº¾÷¯à)¤Îºë¯«ª¬ªp´ú¸Õ(Mini-mental State Examination, »{ª¾ªº¼Ð·Ç´ú¸Õ)¡CªíÅSMCI¼x­Ôªº±wªÌ¾Ö¦³¿©±wªü¦Õ´þ®üÀq¤ó¯f(Alzheimer's Disease, AD)ªº°ª«×­·ÀI¡C¤Î¦­ªº¶EÂ_±N¦³§Q¨ä¦­´ÁªvÀø¦Ó¥¦¥i¯à¨ó§U¸g¿©±w¥i°f©Ê·ö§b(Reversible Forms of Dementia)ªº­Ó¤H«ì´_¥¿±`¡C

³q±`¦³³\¦hºØªº·ö§b¯f·½¡A¦ý¤j¦h§¡Âk¦]©ó´¼¯à¾÷¯àªº³à¥¢¡A°O¾Ð·l®`¡A§PÂ_³à¥¢¥H¤Î­Ó©Ê§ïÅܦӨӡC·ö§bÁÍ©ó¤é¯qÄY­«¦Ó¦³¨Ç«o¦¨¬°¤£¥i°fªº¯gª¬¡CµL½×¦p¦ó¡A·ö§b¥i¥Ñ°ò¥»ªº¯e¯f¹Lµ{(Disease Process)¤©¥HªvÀø¡C·ö§bªº¥i°f­ì¦]¡A¥]¬A¤¤¼Ï¯«¸g¨t²Î·P¬V(Central Nervous System Infection)¡A¸£¸~½F(Trauma or Tumors)¡BºC©Ê¸£¦å¯e¯f(Chronic Cerebrovascular Disease)¦³Ãö³sªº¦h¤¸±ð¶ë·ö§b(Multi-infarct Dementia)¡A¥¿±`À£¤O¤ô¸£(Normal Pressure Hydrocephalus)¡BWernicke-Korsalkoff¼x­Ô¡Bºû¥Í¯À¯Ê¥F¯e¯f(Vitamin Deficiency Disease)¥H¤Î¯«¸g©Ê¯f¯g(Neurological Disorders)½Ñ¦p¦h¤¸µw¤Æ(Multiple Sclerosis)¡B¤Úª÷¥Í¯e¯f(Parkinson's Disease)¤Î¨ä¥Lµ¥¡C

¾¨¥i¯à¤©¥H¦­´Á¶EÂ_·ö§b¡A«h¥i¨Ï¨ä¿n·¥ªvÀø¡A¥H§Q¥i¯à¤©¥H§í¨î¯f±¡ÂX¤j¶i®i¡C¨â­Ó³Ì´¶¹M¦Ó¤£¥i°fªº·ö§b­ì¦]¡A¬°¦åºÞ¯e¯f(Vascular Disease)»Pªü¦Õ®üÀq¤ó¯f¡C¦åºÞ·ö§b(Vascular Dementia)³QºÙ¬°«Y¦~¦Ñ¦¨¤H²Ä¤G´¶¹M«¬ªº·ö§b¡C¥Ñ©ó¨ä¿©±w²v(morbidity)»P¦º¤`²v(Mortality)ªº¨â¤j­ì¦]¡A«Y»P¦åºÞ¯e¯f¡A¤¤­·(Stroke)¥H¤Îµ´¦å¤ßŦ¯f(Ischemic Heart Disease)¦³©ÒÃö³s¡A¦]¦¹¦åºÞ¯e¯f¥i¯à¥ç¬°¨ä¥L·ö§bªº¿©±w¦]¯À¡C¤j¦åºÞ¯e¯f(Large Vessel Disease)«Y»P¦h¤¸±ð¶ë·ö§b¦³©ÒÃö³s¡A¥H­P²Õ´³à¥¢·U¨Ó·UÄY­«¡C¤p¦åºÞ¯e¯f(Small Vessel Disease)¡A³q±`·|¾É­P³´ºÛ¤¤­·(Lacunar Strokes)¡C¤ß¦åºÞ¯e¯f(Cardiovascular Disease)¡A¤×¨ä»P¨Ï¥Î¤ß»PªÍ¶¡¹D¾÷¾¹(Cardiopulmonary Bypass Machine)¦³©ÒÃö³sªº«aª¬°Ê¯ß¶¡¹D²¾´Ó(Coronary Artery Bypass Grafts, CABG)¥H¤Î¥R¦å¤ßŦ°IºÜ(Congestive Heart Failure)¡A¥ç»P¤é¯q¼W¶iªº·ö§b¦³Ãö³s¡CCABG¿©±wªÌ¥i¯àµo¥Í·ö§b¡A«Y¥Ñ©ó¨ä»P¥~¬ì¤â³N¦³ÃöªºÅn­F®MÅ|(Emboli)¦Ó¨Ó¡CµM¦ÓÅn­F®MÅ|¥i¯à¥Ñ©ó®ñ¤Æ¨È´á(Nitrous oxide)©Î³Â¾KÃÄ®ðÅé(Anesthetic Gases)¡A¥Ñ¤ß¦åºÞ©Ò²£¥Íªº¦å®ê(Thrombi)¡A©Î¯×ªÕ©ÎµL¾÷¦å®êµ¥¡A¦Ó²£¥Í¡C³q±`¤ñ¥Ø«e³Q¶EÂ_ªÌ¡A¦ü¥G¦³§ó¦hªº·ö§b¡A«Y¥Ñ¦åºÞ¯e¯f¦Ó¨Ó¡C

³Ì´¶¹M«¬ºAªº·ö§b¬°ªü¦Õ´þ®üÀq¤ó¯f(AD)¦Ó¥¦ªº¶i®i«Y¥iÅܪº¦Ó¨ä¼x­Ô«YÀH­Ó¤H¦Ó¾Ö¦³¤£¦Pªº³t²v¡CDr. Alois Alzheimer¦b1903¦~­º¦¸µo²{³o­Ó¼x­Ô¡A¦ý¥¦¨Ã¤£¹ð¨£¦Ó¥i¯à«Y¥Ñ©ó¦b¤@¥@¬ö«e¡A¹ï¥Í©R«ùÄòªº´Á«Ý¬Æµu©Ò­P¡C·í¤H­Ì¥Í©R¸û¬°¼Wªø«á¡AAD§ó¬°´¶¹M¡A¦Ó¦UºØ¯f·½³Q°²³]¡A¥]¬A¨Ï¥Î¾T»s²i¶¹¥Î¨ã¤Î¾Tºä©Ò­P¡C³o­Ó²z½×¡A¸g±j¦³¤Oªº¬ì¾Ç¬ã¨s¡A·~¤w³Q±À½¡C¥Í²z¾÷¯à¯f­ì¤ÎAD¶i®iªº¦³Ãö¬ã¨s©Ý®i¬Æ¬°¬¡µ¸¨Ã«ùÄò®i¶}¥H§QŲ©w¨ä¯S©Ê¡A¨Ò¦p¯«¸g­MÅé¼ßªº¯S®í¶Ý¥ì¬õ¦å²yµ²ºc(Characteristic Eosinophilic Structures in Neuro Cytoplasm)¡A¥¦¥i¯à´£¨Ñ§ó¦h¸ê°T¡A¥H§Q¹w¨¾©ÎªvÀø³oºØ¥i©Èªº¯e¯f¡C¤AñQÁxÆPà­ú@§í¨î¾¯(Acetyl Cholinesterase Inhibitor)¡A«DÃþ©T¾J§Ü®øª¢Ãľ¯(Non-steroidal Anti-inflammatory Drugs)¡A²üº¸»X¡Aºû¥Í¯À¥H¤ÎÃį󵥦³ÃöªºªvÀøªk¡A§¡´¿³Q´ú¸Õ¡A¥H§Q§í¨î³oºØ¯e¯fªº¶i®i¡CµM¦Ó³o¨ÇªvÀø¤¤¦³¨Ç¥i´Á«Ý¦Ó¥i¥H´x±±ªº¨M©w©ÊÁ{§É¸ÕÅç¡A«o¥¼´¿³Q´£¥X³ø§i¡C

ªñ¨Ó¡A¸û·sªº¯g­Ô¸s¡AºÙ¬°²V¦X·ö§b(Mixed Dementia, MD)¡A·~¤w³QŲ©w¡C¥¦¦ü¥G¾Ö¦³¯f²z®Ú¾Ú¦ÓÅã¥Ü¦åºÞ·ö§b»PAD¡C´X¥G©Ò¦³ªº¥Ø«e¤åÄm¡A§¡±j¯Pªº±ÀÂË¥²¶·¸g§ó¦hªº¬ã¨s¥H¨M©w·ö§bªº¯f·½¡B¶EÂ_¥H¤ÎªvÀø¥ÎÃĵ{¦¡¡A¥H§Q´î»´©Î§í¨î³oºØ·ö§b¯gªº¶i®i¡A©Î¦Ü¤ÖÅý¦b¤H¥Í«á´Á¿©±w·ö§bªÌ¡A¾Ö¦³§ó¨Îªº¥Í¬¡ª¬ªp¡C

ÁöµMºû¥Í¯ÀC»PEªº§@¥Î¨¤¦â©|¦b¬ã¨s·í¤¤¡A¦ý»Pºû¥Í¯ÀB¸s(¤×¨äB6»PB12)¤£¦P¡A·ö§bªºÀç¾i¯f­ì¡A¥¼´¿½T¹ê¦a³QŲ©w¡CµL½×¦p¦ó¡A©|¦³³\¦hÀç¾i¤è­±ªº¬D¾Ô¡C¹ï©ó·s³¯¥NÁ¹L²±(Hypermetabolic)ªº·ö§b±wªÌ¡AÁöµM¦³¨Ç²z½×¬Ýªk¡A¦ý¤åÄm³ø¾ÉÅã¥Ü¨ÃµL¤@ºD©Ê¡C¦³¨Ç¿©±wªÌ¬¡°Ê¹L«×(Hyperactive)¡AµM¦Ó¦³¨Ç«o¸g±`¦h§¤¦Ó¶Ý¯v¡C

Àç¾i°ÝÃD¤j¦h«Y»P´î¤ÖÄá¨ú©Î¦³®É»P¯Ê¥F«D­¹«~¦]¯À¦³Ãö¡A½Ñ¦p¡A³ø¯È¡Bªá¥c¹¢ª«¡B«C¯ó¥H¤Î¨ä¥L«GÄR¦³§l¤Þ©Êªº¨Æ¥ó³vº¥¯Ê¥F©Î´î¤Ö©Ò­P¡C·ö§b±wªÌ¡A³q±`¾Ö¦³µu¼Èªº©Î¹s¬Pªº±Mª`«ùÄò®É¬q(Sparadic Attention Spans)¦Ó¸û¬°®e©ö¤À¤ß¡C¦b§ó¬°µÎ¾AªºÀô¹Ò¤U¡Aµ¹¤©¸û¨Îªº¿¯­¹¦ë¨ü¡A¤]´N¬O­º±À¦wÀR»P¨}¦n·Ó©ú¨â¶µ¬°­n¡C°ª«×·ö§b±wªÌ¥i¯à»Ý­n¤©¥HÁý¾i¦Ó¥ÎÀ\®É¶¡¥²¶·¸g¦Ò¶q¤©¥H²Å¦X¨C­Ó¯f±wªÌªºÄá¨ú§Þ¥©¡A©Ò³ßÅw­¹ª«¡A¥H¤ÎÀç¾i»Ý¨D¬°­n¡C¤£ÅU·ö§b¯f­ì¡AÀç¾i»P­¹ª««Y¥Í¬¡ªº«~½è­n¥ó¡A¦Ó¥¦«Y°·±d¾·~¤Hªº»Ý¨D»PÀ³¨üªº·ÓÅU¡C

¦^¤W­¶


¦³Ãö¶À¨§
¡@The Soybean Story
¬ü°ê¶À¨§¥X¤f¨ó·|ªu­²
¡@Introduction to the American Soybean Association-IM
¶À¨§¥«³õ³ø§i
¡@Soybean Trade Reports
§Þ³N¤åÄm
¡@Technical Bulletin
¬¡°Ê¸ê°T
¡@Activities Bulletin
¶À¨§¤§¤u·~À³¥Î¤ÎÀô«O
¡@Application in Environmental Protection Industry
¦³Ãö¥Íª«¬ì§Þ
¡@Biotechnology
¥xÆW¶À¨§¥[¤u¤Î¬ÛÃö¦æ·~Á`Äý
    Soybean Related Industries 

¦^­º­¶  Home